---
figid: PMC6834863__nihms-1027768-f0002
figlink: pmc/articles/PMC6834863/figure/F2/
number: F2
caption: 'Schematic of the different apelinergic signaling pathways. The activation
  of apelin receptor by its endogenous ligands, apelin or Elabela, triggers various
  signaling pathways that exert protective cardiovascular and metabolic effects in
  the organism. Some of the transcriptional gene regulation effects following the
  activation of apelinergic pathway are depicted in the nucleus. Abbreviations: AC,
  adenylate cyclase; ACE2, angiotensin-converting enzyme 2; Ang II, angiotensin II;
  APLNR, apelin receptor; AT1R, angiotensin type 1 receptor; βARR, β-arrestins; eNOS,
  endothelial nitric oxide synthase; ERK1/2, extracellular-regulated kinases 1/2;
  FABP4, fatty acid binding protein 4; FOXO1/3, forkhead box protein O1/3; KDR, kinase
  insert domain receptor (also known as VEGFR2); MLCK, myosin light chain kinase;
  NEP, neprilysin; SIRT3, sirtuin 3; VEGFA, vascular endothelial growth factor A.'
pmcid: PMC6834863
papertitle: 'The apelinergic system: a perspective on challenges and opportunities
  in cardiovascular and metabolic disorders..'
reftext: Eric Marsault, et al. Ann N Y Acad Sci. ;1455(1):12-33.
pmc_ranked_result_index: '25332'
pathway_score: 0.9608123
filename: nihms-1027768-f0002.jpg
figtitle: The different apelinergic signaling pathways
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6834863__nihms-1027768-f0002.html
  '@type': Dataset
  description: 'Schematic of the different apelinergic signaling pathways. The activation
    of apelin receptor by its endogenous ligands, apelin or Elabela, triggers various
    signaling pathways that exert protective cardiovascular and metabolic effects
    in the organism. Some of the transcriptional gene regulation effects following
    the activation of apelinergic pathway are depicted in the nucleus. Abbreviations:
    AC, adenylate cyclase; ACE2, angiotensin-converting enzyme 2; Ang II, angiotensin
    II; APLNR, apelin receptor; AT1R, angiotensin type 1 receptor; βARR, β-arrestins;
    eNOS, endothelial nitric oxide synthase; ERK1/2, extracellular-regulated kinases
    1/2; FABP4, fatty acid binding protein 4; FOXO1/3, forkhead box protein O1/3;
    KDR, kinase insert domain receptor (also known as VEGFR2); MLCK, myosin light
    chain kinase; NEP, neprilysin; SIRT3, sirtuin 3; VEGFA, vascular endothelial growth
    factor A.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MME
  - ACE2
  - APLNR
  - ADCY2
  - ADCY3
  - ADCY5
  - ADCY6
  - ADCY8
  - ADCY9
  - ADCY10
  - ADCY4
  - ADCY1
  - ADCY7
  - SIRT3
  - MAPK3
  - MAPK1
  - AKT2
  - AKT3
  - AKT1
  - F3
  - KDR
  - VEGFA
  - FABP4
  - ATP
  - L-Arginine
  - hypertrophy
genes:
- word: NEP
  symbol: NEP
  source: hgnc_alias_symbol
  hgnc_symbol: MME
  entrez: '4311'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: APLNR
  symbol: APLNR
  source: hgnc_symbol
  hgnc_symbol: APLNR
  entrez: '187'
- word: APLNR
  symbol: APLNR
  source: hgnc_symbol
  hgnc_symbol: APLNR
  entrez: '187'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: (SIRT3
  symbol: SIRT3
  source: hgnc_symbol
  hgnc_symbol: SIRT3
  entrez: '23410'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: FOX01/3
  symbol: F3
  source: hgnc_symbol
  hgnc_symbol: F3
  entrez: '2152'
- word: KDR
  symbol: KDR
  source: hgnc_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: VEGFA
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: ACE2
  symbol: ACE2
  source: hgnc_symbol
  hgnc_symbol: ACE2
  entrez: '59272'
- word: FABP4
  symbol: FABP4
  source: hgnc_symbol
  hgnc_symbol: FABP4
  entrez: '2167'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: L-Arginine
  source: ''
  identifier: ''
diseases:
- word: hypertrophy
  source: MESH
  identifier: D006984
figid_alias: PMC6834863__F2
redirect_from: /figures/PMC6834863__F2
figtype: Figure
---
